With pharmaceutical pricing growing at an exponential rate, countries world wide are trying to get a handle on how exactly pharmaceutical companies are deciding at what price to sell their drugs. When using a country’s wealth as the deciding factor, it’s no wonder patients in the U.S. are suffering – when the country’s wealth belongs to only the top 1 percent! Read more here. (Source: The Medical Quack, 10/7/14).
You are here: / / Is Pharmaceutical Pricing In The U.S. Based On Fake Wealth?